Eisai Clinical Trials

A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures


Study Overview

NCT00144690, EU CTR 2005-004199-18
Mar 2005 - Feb 2007
Determination of the maximum tolerated dose (MTD)

  • Males and females (age 18 to 70 years)

  • Completed

  • Phase 2

  • Australia, Czech Republic, Germany, Lithuania, Sweden, United Kingdom, United States See more


CSR Synopsis

No download available

Lay Summary

No download available

Publication reference citation

Krauss GL, Bar M, Biton V, Klapper JA, Rektor I, Vaiciene-Magistris N, et al. Tolerability and safety of perampanel: Two randomized dose-escalation studies. Acta Neurol Scand 2012 01;125(1):8-15. DOI: 10.1111/j.1600-0404.2011.01588.x

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

Redacted documents are available upon request for this study.

Document type Availability
Sample CRF
Full CSR